Suspicious adnexal mass mimicking an ovarian malignancy; Case presentation
- 20 November 2019
- journal article
- Published by Digital ProScholar Media in Journal of Clinical and Investigative Surgery
- Vol. 4 (2), 108-113
- https://doi.org/10.25083/2559.5555/4.2/108.113
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Imaging and Differential Diagnosis of Ovarian CancerSeminars in Ultrasound, CT and MRI, 2019
- Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal massesAmerican Journal of Obstetrics and Gynecology, 2019
- Multiple biomarker algorithms to predict epithelial ovarian cancer in women with a pelvic mass: Can additional makers improve performance?Gynecologic Oncology, 2019
- Valeur diagnostique de l’imagerie (échographie, doppler, scanner, IRM et TEP-TDM) pour le diagnostic d’une masse ovarienne suspecte et le bilan d’extension d’un cancer de l’ovaire, des trompes ou péritonéal primitif. Article rédigé sur la base de la recommandation nationale de bonnes pratiques cliniques en cancérologie intitulée « Conduites à tenir initiales devant des patientes atteintes d’un cancer épithélial de l’ovaire » élaborée par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY sous l’égide du CNGOF et labellisée par l’INCaGynecologie, Obstetrique, Fertilite & Senologie, 2019
- Ovarian cancer statistics, 2018CA: A Cancer Journal for Clinicians, 2018
- Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis groupAmerican Journal of Obstetrics and Gynecology, 2016
- A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer — An international multicenter study in women with an ovarian massGynecologic Oncology, 2015
- Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic studyBMJ, 2014
- Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal massesEuropean Journal of Cancer, 2012
- Diagnostic performances of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseasesClinical Biochemistry, 2011